ResearcherUniversity of MilanActive in the last 2 years
Alessandro Michele Bonomi
Matched on ORCID iD 0000-0002-7248-197X; OpenAlex author ID A5004206048. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers
Papers 3
- Impact of R0/R1 Margin Status on Overall Survival in Node-Positive Resected Pancreatic Ductal Adenocarcinoma: Meta-Analysis. Co-author DOI 10.1245/s10434-026-19850-4↗
- ASO Author Reflections: R0 Resection Should Not Be Dismissed in Node-Positive Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-026-20047-y↗
- The Role of Non-Peripancreatic Lymph Nodes in the Survival of Patients Suffering from Pancreatic Cancer of the Body and Tail: A Systematic Review and Meta-Anal… Co-author DOI 10.3390/cancers15082322↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Stefano Granieri · 3 shared papers, 2023–2026 · strength 0.82
- Paper Impact of R0/R1 Margin Status on Overall Survival in Node-Positive Resected Pancreatic Ductal Adenocarcinoma: Meta-Anal… DOI 10.1245/s10434-026-19850-4↗
- Paper ASO Author Reflections: R0 Resection Should Not Be Dismissed in Node-Positive Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-026-20047-y↗
- Paper The Role of Non-Peripancreatic Lymph Nodes in the Survival of Patients Suffering from Pancreatic Cancer of the Body and… DOI 10.3390/cancers15082322↗
- Marc G. Besselink · 2 shared papers, 2026 · strength 0.63
- Paper Impact of R0/R1 Margin Status on Overall Survival in Node-Positive Resected Pancreatic Ductal Adenocarcinoma: Meta-Anal… DOI 10.1245/s10434-026-19850-4↗
- Paper ASO Author Reflections: R0 Resection Should Not Be Dismissed in Node-Positive Pancreatic Ductal Adenocarcinoma. DOI 10.1245/s10434-026-20047-y↗
- Christian Cotsoglou · 1 shared paper, 2023 · strength 0.18
- Simone Frassini · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.